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Serum albumin concentration in dialysis patients: Why does it
remain resistant to therapy? Serum albumin, transferrin, and
prealbumin levels decrease as glomerular filtration rate (GFR)
declines, even prior to the start of dialysis. The levels of these
serum proteins are also associated with creatinine levels and
lean body mass. Lean body mass also decreases with advancing
renal failure. While all of these measures are regarded as re-
flections of nutritional status, each are strongly associated with
any of several indicators of inflammation: positive acute-phase
proteins or the cytokines that regulate their synthesis rate, in
both longitudinal and cross-sectional studies. Inflammation in
turn is associated with comorbid conditions, cardiovascular
disease, chronic infections, age, and vascular access type. Addi-
tionally, dialysis patients are subjected to oxidative stress and
exposure of blood to foreign antigens in the dialysis process
that also potentially contribute to inflammation. In otherwise
healthy individuals reduced protein and calorie intake does
not cause hypoalbuminemia since albumin fractional catabolic
rate (FCR) and resting energy expenditure (REE) normally
decrease in response. The simultaneous occurrence of de-
creased protein intake and inflammation prevent these homeo-
static compensations to reduced nitrogen and energy intake from
occurring, resulting in decreasing albumin, transferrin, and pre-
albumin levels and loss of muscle mass. Nutritional intake
may also be challenged as a result of renal failure associated
with anorexia, gastroparesis, and socioeconomic factors, which
may all cause nutritional intake to be sufficiently marginal so
that the combined effects of inflammation and decrease pro-
tein intake are expressed as decreased visceral and somatic
protein stores.
Albumin levels are lower in dialysis patients than
among the general population and are a powerful pre-
dictor of mortality [1]. There has been little or no prog-
ress in increasing albumin levels in the prevalent dialysis
patient population in over 10 years, despite the wide
introduction of biocompatible dialyzers and a trend to-
ward increasing dialysis dose [2]. Albumin levels are
controlled by the rate of albumin synthesis, albumin frac-
tional catabolic rate (FCR), and albumin distribution
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between the vascular and extravascular compartment.
These in turn are affected by both nutrition [3] and, since
albumin is a negative acute-phase protein, by inflamma-
tion [4]. Additionally, plasma volume expansion can di-
lute the plasma pool. A rather profound reduction in
both calorie and protein intake is, however, not generally
associated with reduced levels of albumin or prealbumin
(transthyretin) in otherwise healthy individuals [5], sug-
gesting that factors other than reduced protein, and calo-
rie intake alone, play a role in altering serum protein
levels in patients with chronic kidney disease. What are
these factors and what are the prospects for improving
nutritional status in dialysis patients?
Prior to the initiation of dialysis both protein and calo-
rie intake generally decline [6]. The evidence for this is
from measured reduction in urinary urea nitrogen ap-
pearance, dietary records, and the increased incidence
of reduced serum concentrations of albumin and trans-
ferrin, both nutritional markers. Preservation of calorie
intake during consumption of a low-protein diet is, how-
ever, not associated with hypoalbuminemia in this popu-
lation, if otherwise healthy [7, 8]. Why then is reduction
in protein and calorie intake reflected in alteration of
serum protein composition? One explanation for this is
that both albumin and transferrin are also negative acute-
phase proteins.
MALNUTRITION ARISES FROM PROCESSES
BEYOND INADEQUATE NUTRIENT
INTAKE ALONE
While calorie and protein intake are less than optimal
in patients as they approach end-stage renal disease
(ESRD), the magnitude of reduced nutrient intake is
insufficient, that if acting alone should result in decreased
levels of visceral or somatic protein mass. In a study
conducted in Minnesota over 50 years ago, healthy vol-
unteers were subjected to semi-starvation (1500 kcal/
24 h) for 24 weeks. Despite a 23% reduction in body
weight (from 69.3 to 53.6 kg) and muscle mass, serum
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Fig. 1. Relationship between normalized protein catabolic rate
(nPCR), C-reactive protein (CRP) level, and serum albumin concentra-
tion in 287 hemodialysis patients. Note that the relationships are non-
linear. The relationship between albumin and CRP is above a value of
12 mg/L and between albumin and nPCR is below a value of approxi-
mately 1.0 g/kg/day. Data and figure are adapted from [40] with permis-
sion.
albumin decreased only moderately (from 4.28 to 3.86
g/dL) [9]. This study suggested that when serum albumin
concentration was reduced to very low levels that addi-
tional processes contribute.
It is unusual to find serum albumin decreased to values
less than 3.0 g/dL in the absence of both inflammation
and malnutrition. One may use normalized protein cata-
bolic rate (nPCR) as a surrogate of nitrogen catabolism,
which at steady state should approximate dietary nitro-
gen intake. Using this assumption, one finds that the
serum albumin concentration is described by a surface
relating the independent effects of nPCR and with the
levels of the acute phase protein C-reactive protein
(CRP) (Fig. 1). These relationships are nonlinear. Unlike
what occurred in the controlled Minnesota study [9],
and what is described for subjects with pure anorexia
nervosa, as nPCR declines in dialysis patients, so does
serum albumin concentration, and the quantity of this
decline is dependent upon the incident level of CRP
(Fig. 1). These observations suggest that dialysis patients
are subject to stresses beyond protein and calorie restric-
tion alone, and that one important factor in this relation-
ship is that imparted by inflammation.
At progressively greater levels of CRP, serum albumin
concentration decreases even if nPCR values are high
(Fig. 1). These observations must be viewed in the con-
text that the lower limit of sensitivity of the assay for
CRP employed in this study was approximately 5 mg/L
and thus may mask clinically significant levels of in-
flammation, well into the range where CRP predicts
cardiovascular disease [10]. Thus, dialysis patients are
sufficiently inflamed so that their serum protein concen-
tration is influenced by nutrition, far more so than would
be expected of an individual without underlying in-
flammation.
Ikizler [11] observed in hospitalized dialysis patients
that nPCR greatly overestimated nitrogen intake. Thus,
hospitalized dialysis patients were, in addition to having
a lower than acceptable nPCR, in negative nitrogen bal-
ance. Thus, it is possible that in the presence of acute
disease or inflammation that nPCR may actually over-
estimate protein intake, masking negative nitrogen bal-
ance. The major problems with the “nutrition only”
model of hypoalbuminemia in dialysis patients are the
observations that both short-term fluctuations in serum
albumin concentration [12], as well as stable and long-
lived decreases in serum albumin concentration [13, 14],
are accompanied by evidence of activation of the acute-
phase response, but not of significant changes in nPCR.
While this may reflect a mismatch between nitrogen con-
sumption and catabolism, it is very clear that during
periods of inflammation albumin synthesis is suppressed
[15], and the fractional rate of albumin catabolism is
greater than would normally occur [13] for a given level
of serum albumin concentration [3], suggesting that albu-
min levels are strongly influenced by the effects of in-
flammation, regardless of nitrogen availability.
INFLAMMATION IN RENAL FAILURE
The average levels of acute-phase proteins are in-
creased in dialysis patients when compared to normal
subjects or to patients not yet on dialysis [16, 17]. In-
flammation is strongly associated with cardiovascular
risk in the general population [10, 18] and in patients
with renal failure as well [16, 19, 20]. Indeed, when ana-
lyzed by multiple regression analysis, CRP levels replace
albumin as a predictor of all-cause and of cardiovascular
mortality [19]. As renal function declines so does dietary
protein and energy content [6]. While there are several
factors that may play a role in the anorexia that accompa-
nies progressive loss of renal function, nPCR increases
following initiation of hemodialysis treatment [21] and
so does serum albumin concentration. A component of
the increase in the prevalent dialysis patient is the attri-
tion of the most malnourished patients [22]; however,
among the survivors, albumin levels do increase during
the first year [22]. This may well be a result of improved
nutrition or to the removal of uremic toxins. However,
this is then followed by a decline in both parameters.
The low albumin levels that are encountered in incident
dialysis patients are likely a consequence of a combina-
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tion of protein-calorie malnutrition, inflammation, and
plasma volume expansion, which are present just prior
to the initiation of dialysis therapy [23]. Albumin concen-
tration and nPCR both increase during the first six
months of dialysis therapy [24], suggesting that correc-
tion of the nutritional factors indeed has a salutary effect
on albumin levels. However, after the first year, albumin
levels decline [21, 25]. This may be due to a loss of
residual renal function or the accrual of comorbid condi-
tions that have the potential to suppress appetite or to
activate the systemic inflammatory response, or both.
RESPONSE TO REDUCED NUTRIENT
INTAKE IN THE PRESENCE AND
ABSENCE OF INFLAMMATION
Hypoalbuminemia does not normally occur in other-
wise healthy but malnourished individuals until near ter-
minal starvation [5]. One mechanism for preservation of
tissue mass is a reduction in resting energy expenditure
(REE) [5, 26, 27]. Similar mechanisms occur in un-
inflamed dialysis patients [28], suggesting that renal fail-
ure, per se, does not disrupt these homeostatic mecha-
nisms. By contrast, patients with wasting and infection
with the human immunodeficiency virus (HIV) exhibit an
increased REE that is even more marked in the presence
of diagnosed infection [29]. This is also true of patients
with chronic lung disease [30], cancer [31, 32] and in
patients with renal failure [28, 33, 34]. Harty [35] noted
that there was no relationship between REE and nutri-
tional state among peritoneal dialysis patients and sug-
gested that this inability to conserve energy may act as
an additional risk factor for ongoing malnutrition. The
most parsimonious explanation for the failure of patients
with renal failure from reducing REE appropriately is
that they, like patients with other chronic illnesses, are
subject to the systemic inflammatory response [16, 36].
One mechanism whereby inflammation impairs the
capacity of patients to defend their albumin mass is by
the interaction between inflammation, albumin FCR,
and serum albumin level. When protein intake is re-
duced, so is albumin synthesis [3, 37–39]. As albumin
levels decline in response to the decrease in synthetic
rate, so does albumin FCR [3]. This normal homeostatic
mechanism acts as a counter-regulatory support in the
presence of reduced protein and calorie intake. Albumin
FCR is directly proportional to the serum level of long-
lived acute-phase proteins in dialysis patients indepen-
dently of albumin concentration [13]. However, if one
adjusts albumin FCR for the level of either the long-
lived acute-phase protein 1 acid glycoprotein or cerulo-
plasmin (Fig. 2), the relationship between albumin level
and albumin FCR described in the absence of inflamma-
tion [3] reappears [13]. Thus, inflammation and nutrition
interact in at least two ways to alter albumin concen-
Fig. 2. Relationship between albumin fractional catabolic rate (FCR),
serum albumin concentration, and ceruloplasmin concentration in 64
hemodialysis patients at the time that albumin FCR was measured by
the disappearance of [125I] human serum albumin. Albumin FCR was
the percent of the plasma albumin pool catabolized per day. Plasma
albumin pool was the product of plasma albumin concentration and
plasma volume. Individual data points by open circles. Data obtained
from [13].
tration, through their effects on both albumin synthesis
and FCR.
Using normalized protein catabolic rate (nPCR) as
a measure of protein intake, we have established an
interaction between nPCR and serum albumin concen-
tration if controlled for a marker of inflammation, either
CRP [16, 40] or serum amyloid A (SAA) [41]. While
albumin level was independently correlated with both
nPCR and the level of these acute-phase proteins, the
acute-phase proteins were more strongly and indepen-
dently associated with albumin levels than was nPCR
(Fig. 1).
NUTRITIONAL AND NON-NUTRITIONAL
FACTORS INTERACT TO CONTRIBUTE
TO CHANGES IN PLASMA AND
BODY COMPOSITION
Complicating the relationship between measures of
nutritional outcome (serum albumin, transferrin, pre-
albumin levels, lean body mass) and dietary energy and
protein intake is the association between hypoalbumi-
nemia and other comorbid conditions that are either
associated with inflammation or with hypoalbuminemia
independently of inflammation. Comorbid conditions
that are associated with low albumin levels [42], diabetes,
peripheral vascular disease, smoking, neoplasms, and ei-
ther temporary vascular access or A-V grafts are also
associated with increased prevalence of infection [43, 44]
or with inflammation. Dialysis patients also have in-
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Fig. 3. Relationships between inflammation,
decreased nutrient intake, protein, malnutri-
tion, and change in serum protein composition
and muscle mass. Inflammation and malnutri-
tion lead to decreased synthesis of visceral
proteins. Cytokines, as well as uremic toxins,
also reduce appetite, adding to the effect of
inflammation on visceral protein levels. Tu-
mor necrosis factor  (TFN) also causes
apoptosis of adipocytes and decreases muscle
protein synthesis, impeding recovery from
malnutrition.
creased incidence of infectious diseases, such as tubercu-
losis [45]. Age and volume overload [46] also are inde-
pendently associated both with hypoalbuminemia and
with inflammation. In addition to their direct effect on
serum protein concentration, cytokines [47, 48] and other
comorbid conditions suppress appetite, as well as in-
crease a patients’ vulnerability to the effects of malnutri-
tion (Fig. 3). Additionally, gastric emptying disorders are
associated with diabetes and other comorbid conditions
common in dialysis patients and may directly affect nutri-
ent intake [49].
Another factor associated with loss of renal function
is the development of metabolic acidosis as a result of
reduced renal acidification. Metabolic acidosis also can
suppress albumin synthesis [50] and promote skeletal
muscle catabolism [51, 52]. Thus, it might also be reason-
able to speculate that metabolic acidosis plays a role in
causing both hypoalbuminemia and loss of muscle mass
in dialysis patients, thus providing an additional thera-
peutic avenue to approach.
THE EFFECTS OF NUTRITIONAL STATUS ARE
LONG LASTING AND MAY RESULT FROM
DIFFICULT-TO-REVERSE PROCESSES
Nutritional status prior to the onset of dialysis predicts
survival both in the short-term [53], and even after five
years of follow-up [42]. Furthermore, while nutritional
status improves within the most malnourished patients
during the first year of renal replacement therapy, base-
line measures of malnutrition predict that serum albumin
and prealbumin values will remain low even after a year
of dialysis [54]. Other investigators have found no im-
provement in albumin levels during the first year of treat-
ment with hemodialysis [21]. Thus, either the effects of
malnutrition are long lived in this population or malnu-
trition reflects other morbidity that may not be easily
reversible, or both. Following the first year of dialysis
no clear trend in serum albumin values is evident [55]. In
contrast to albumin values, measures of somatic protein
mass, creatinine [40], phase-angle [55], a measure that
correlates with lean body mass, decrease with time. The
change in creatinine [40] is associated with CRP levels,
while the changes in phase angle correlate with the cyto-
kine interleukin-1 (IL-1) [55], suggesting a cumulative
effect of the inflammatory response.
Comorbidity is strongly associated with hypoalbumi-
nemia in the dialysis patient population [22, 42–46].
Many of these factors, such as vascular disease and
chronic obstructive pulmonary disease (COPD), are not
readily reversible, but most likely contribute indirectly
to malnutrition by their association both with anorexia
and inflammation. Other factors, such as vascular access
type, may be more amenable to therapy. Not surpris-
ingly, albumin concentration tends to decline among pa-
tients in the six months prior to death [22].
Inflammation may both directly reduce measures that
are used to establish nutritional status (lean body mass,
serum albumin, and prealbumin levels), and also affect
nutritional intake, making it appear that the two are
linked, while instead each has an independent effect
(Fig. 3). Associations between dietary protein intake (or
nPCR as a surrogate marker) and hypoalbuminemia may
not then be causally linked. Renal failure, per se, leads
to increased levels of leptin [56–58] and other possible
appetite suppressive substances [59, 60], making it diffi-
cult to maintain nutritional intake at desirable levels in
patients with ESRD. Cytokines also directly suppress
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appetite. Therefore, care must be taken in interpretation
of cross-sectional associations.
WHAT IS THE EFFECT OF IMPROVED
NUTRIENT INTAKE?
Cano [61] compared lean body mass, predialysis creati-
nine, prealbumin, and albumin levels in a group of dia-
betic and non-diabetic patients and found that, while all
of these parameters were significantly reduced in the
diabetic patients, nPCR was not in comparison to the
non-diabetic subjects. Interventional experimental data
therefore is necessary to establish the effect of nutrition
as compared to associations between nutrient intake and
manifestations of clinical malnutrition in patients. These
data have provided mixed results.
Were protein malnutrition the principal cause of hypo-
albuminemia in the dialysis patient population, one
would expect that nutritional supplementation would be
effective in restoring albumin pools, as it is in patients
with hypoalbuminemia caused by protein malnutrition
[3, 62]. Such associations have not been uniformly dem-
onstrated [63, 64]. Oral nutritional supplements or in-
tradialytic parenteral nutrition (IDPN) have proved ei-
ther ineffectual [62, 63, 65] or only partially effective
[66, 67] in repair of hypoalbuminemia of hemodialysis
patients in some studies. Others have had positive effects
on both albumin and prealbumin levels [68, 69], although
these studies were longitudinal using baseline data as
the control, rather than a prospective randomized study
with a control group. The mixed results of nutritional
intervention in correcting hypoalbuminemia suggest that
other factors may be more important, even dominant in
causing reduced albumin concentration in most or a large
fraction of dialysis patients, or at least other factors re-
quire resolution before marked improvement in nutri-
tional status can be achieved.
DIALYSIS DOSE: CAN MORE BE DONE?
Dialysis dose also had no effect on outcome once a
sufficient dose was achieved [70, 71]. When dialysis dose
is inadequate, increasing doses may be associated with
increasing nPCR, suggesting reduction in anorexia an
improving nutritional intake; however, this was not sub-
stantiated in the large prospectively randomized HEMO
study. Thus, improving dialysis dose beyond a urea re-
duction ratio of 66.3  2.5%, a single-pool Kt/V 1.32 
0.09, and the equilibrated Kt/V 1.16  0.08 is unlikely to
produce great benefit with regard to nutritional outcome.
The caveat that must be added to this is that in women,
who have small urea volume of distribution, there was
a survival benefit, suggesting that some benefit might
accrue individuals having low volume of distribution of
urea (Vd urea), but generally one can conclude that
greatly increasing dialysis dose using the current model
of thrice weekly dialysis is unlikely to have a dramatic
impact on survival or nutritional outcomes.
METABOLIC ACIDOSIS
Metabolic acidosis has been demonstrated to cause a
decrease in the rate of albumin synthesis in acute studies
[50]. Of interest, in patients with renal failure, serum
bicarbonate levels are nearly uniformly found to be in-
versely correlated with serum albumin concentration [22,
72, 73]. Kirschbaum [74] reported that methods of collec-
tion of serum specimens for laboratory analysis in dial-
ysis units may lead to artifactually low measured levels
of bicarbonate. While this effect would lead to reduced
precision in the relationship between bicarbonate and
albumin levels, it would not explain the strong inverse
relationship observed.
Interventional studies, likewise, have not demon-
strated a robust positive effect of correction of metabolic
acidosis on serum albumin concentration [75, 76]. Since
dietary acid and protein are generally linked, it is likely
that the statistical correction for the interaction between
dietary protein and serum bicarbonate is insufficient to
correct for its biologic effect.
SOCIAL AND ECONOMIC FACTORS
CONTRIBUTING TO MALNUTRITION
Social and economic issues that may play a role in
inadequate nutritional intake may provide a fruitful ave-
nue to approach. Leon et al [77] used a systems-based
approach to improve nutritional intake in dialysis pa-
tients that has been successful in improving actual nutri-
tional outcome measures even when controlled for in-
flammation (CRP levels). Both retrospective [78] and
prospective studies [79] of nutritional supplementation
suggest that dietary intervention has the potential to
effectively correct the progressive malnutrition in dial-
ysis patients. Unlike cytokine- or uremic toxin-induced
anorexia, social and economic barriers to access to ade-
quate nutrition are solvable given adequate resources to
solve these problems.
CONCLUSION
Malnutrition, at least as defined by reduced levels of
albumin, prealbumin, and transferrin, is a result of com-
bined effects of inflammation and inadequate protein
and calorie intake. The causes of inflammation are sev-
eral, but include comorbid conditions that may not be
immediately reversible. In addition, both inflammation
and comorbid conditions suppress appetite, which fur-
ther confounds efforts to improve nutritional status.
Small non-randomized studies suggest that nutritional
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supplementation may have some salutary effect. Efforts
aimed at reducing sources of inflammation such as in-
creasing the use of fistulas and identifying and treating
infections may prove of value, while it does not appear
that increasing the dose of dialysis beyond currently rec-
ommended values will likely have a salutary effect. While
metabolic acidosis may contribute also to malnutrition,
clinically, the added effect of protein that normally ac-
companies metabolic acid on balance leads to improved
nutritional status in most patients with acid retention.
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